The Effect of Pain Neuroscience Education

NCT06909461 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2025-06-27

No results posted yet for this study

Summary

The aim of this study is to examine the effect of pain neuroscience education (PNE) on physiotherapy students' knowledge, attitudes and behaviors towards pain. A total of 52 physiotherapy students will be included in the study. Students will be randomly randomly assigned to either PNE group (n=26) or control group (CG) (n=26). The PNE group will be receive a 70-min PNE based on the explanations used in "Explain Pain". The CG group will be received an education about red-flags which are special screening questions for serious pathology. The red-flags education will be discussed tissue pathology and Waddell's triage for back pain classification.Neurophysiology and the biopsychosocial model will not be discussed. Before, immediately after, and 2-months after the education sessions all students will be completed four questionnaires, the Revised Neurophysiology Pain Questionnaire (RNP-Q), the Health Care Providers' Pain and Impairment Relationship Scale(HC-PAIRS), and the red-flags questionnaire.

Conditions

  • Student Education

Interventions

OTHER

Pain neuroscience education

The pain neuroscience education group will be receive a 70-min pain neuroscience education.

OTHER

Red-flags education

The control group will be receive a 70-min red-flags education.

Sponsors & Collaborators

  • Celal Bayar University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-05
Primary Completion
2025-06-05
Completion
2025-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06909461 on ClinicalTrials.gov